OPPtic is a pilot feasibility study establishing and interrogating a clinical opioid pharmacogenomics database in palliative care.
Many people with cancer will require pain relief with opioids at some time in their illness. They are highly effective for most, but a group of people develop significant side effects. Currently, there is no means of predicting who will get these side effects.
This study seeks to elucidate the clinical, biological and genetic factors that influence side effects and efficacy for the opioid drug class in a palliative care population of cancer patients.